ACE2 has been found to be highly expressed in multiple tissues in addition to respiratory epithelial cells, including myocardial cells, and the proximal tubule cells of the kidney and the gut epithelium [47], which may explain the clinical presentation of COVID-19. Here, ACE2 is linked to COVID-19.